JPWO2022081835A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022081835A5 JPWO2022081835A5 JP2023523034A JP2023523034A JPWO2022081835A5 JP WO2022081835 A5 JPWO2022081835 A5 JP WO2022081835A5 JP 2023523034 A JP2023523034 A JP 2023523034A JP 2023523034 A JP2023523034 A JP 2023523034A JP WO2022081835 A5 JPWO2022081835 A5 JP WO2022081835A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- kda
- therapeutic molecule
- domain
- hyaluronan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092251P | 2020-10-15 | 2020-10-15 | |
| US63/092,251 | 2020-10-15 | ||
| US202163250782P | 2021-09-30 | 2021-09-30 | |
| US63/250,782 | 2021-09-30 | ||
| PCT/US2021/054965 WO2022081835A1 (en) | 2020-10-15 | 2021-10-14 | Hyaluronic acid binding derivatives of versican (vg1) for long acting delivery of therapeutics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545514A JP2023545514A (ja) | 2023-10-30 |
| JP2023545514A5 JP2023545514A5 (https=) | 2024-10-23 |
| JPWO2022081835A5 true JPWO2022081835A5 (https=) | 2024-10-23 |
Family
ID=78483243
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523019A Pending JP2023546112A (ja) | 2020-10-15 | 2021-10-14 | 長時間作用型眼送達用非共有結合タンパク質－ヒアルロナンコンジュゲート |
| JP2023523034A Pending JP2023545514A (ja) | 2020-10-15 | 2021-10-14 | 治療薬の長時間作用型送達のためのバーシカン（ｖｇ１）のヒアルロン酸結合誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523019A Pending JP2023546112A (ja) | 2020-10-15 | 2021-10-14 | 長時間作用型眼送達用非共有結合タンパク質－ヒアルロナンコンジュゲート |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20230279090A1 (https=) |
| EP (2) | EP4228706A1 (https=) |
| JP (2) | JP2023546112A (https=) |
| KR (2) | KR20230088743A (https=) |
| CN (1) | CN116390767A (https=) |
| AU (2) | AU2021360935A1 (https=) |
| CA (2) | CA3198668A1 (https=) |
| IL (2) | IL302087A (https=) |
| TW (2) | TW202228790A (https=) |
| WO (2) | WO2022079161A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2025242919A1 (en) * | 2024-05-24 | 2025-11-27 | Navigo Proteins Gmbh | Novel binding proteins for hyaluronic acid |
| WO2026022392A1 (en) * | 2024-07-26 | 2026-01-29 | Ospedale San Raffaele S.R.L. | Peptide and conjugates thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5144088A (en) | 1991-04-26 | 1992-09-01 | Aristech Chemical Corporation | Manufacture of neopentyl glycol (I) |
| JP3957765B2 (ja) | 1997-04-07 | 2007-08-15 | ジェネンテク・インコーポレイテッド | 抗ｖｅｇｆ抗体 |
| DE60140474D1 (de) | 2000-09-08 | 2009-12-24 | Univ Zuerich | Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten |
| US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| LT3216803T (lt) | 2008-06-25 | 2020-06-10 | Novartis Ag | Stabilūs ir tirpūs antikūnai, slopinantys vegf |
| US20140248296A1 (en) * | 2008-10-16 | 2014-09-04 | Kathleen Cogan Farinas | Sustained drug delivery system |
| US8133979B2 (en) | 2008-12-16 | 2012-03-13 | Hoffmann-La Roche Inc. | Antibodies against human angiopoietin 2 |
| LT3495387T (lt) | 2012-07-13 | 2021-11-25 | Roche Glycart Ag | Bispecifiniai anti-vegf / anti-ang-2 antikūnai ir jų panaudojimas akių kraujagyslių ligoms gydyti |
| EP2935589A1 (en) | 2012-12-18 | 2015-10-28 | Novartis AG | Compositions and methods that utilize a peptide tag that binds to hyaluronan |
| US10434188B1 (en) * | 2013-06-04 | 2019-10-08 | The Trustees Of Indiana University | Hyaluronic acid binding domain-growth factor fusion protein cDNAs and fusion proteins for cartilage matrix preservation and repair |
| CN105008791B (zh) | 2013-08-06 | 2017-08-29 | 奥林巴斯株式会社 | 光源光学系统、光纤光源、显微镜和汽车用前照灯 |
| WO2015198243A2 (en) | 2014-06-25 | 2015-12-30 | Novartis Ag | Compositions and methods for long acting proteins |
| WO2016073157A1 (en) | 2014-11-06 | 2016-05-12 | Genentech, Inc. | Anti-ang2 antibodies and methods of use thereof |
| PT3215530T (pt) | 2014-11-07 | 2019-11-21 | Sesen Bio Inc | Anticorpos de il-6 melhorados |
| CA3012718A1 (en) * | 2016-02-08 | 2017-08-17 | Vitrisa Therapeutics, Inc. | Compositions with improved intravitreal half-life and uses thereof |
-
2021
- 2021-10-14 CA CA3198668A patent/CA3198668A1/en active Pending
- 2021-10-14 EP EP21816202.2A patent/EP4228706A1/en active Pending
- 2021-10-14 JP JP2023523019A patent/JP2023546112A/ja active Pending
- 2021-10-14 WO PCT/EP2021/078433 patent/WO2022079161A1/en not_active Ceased
- 2021-10-14 KR KR1020237015502A patent/KR20230088743A/ko active Pending
- 2021-10-14 TW TW110138224A patent/TW202228790A/zh unknown
- 2021-10-14 TW TW110138197A patent/TW202228789A/zh unknown
- 2021-10-14 AU AU2021360935A patent/AU2021360935A1/en active Pending
- 2021-10-14 IL IL302087A patent/IL302087A/en unknown
- 2021-10-14 AU AU2021361108A patent/AU2021361108A1/en active Pending
- 2021-10-14 IL IL302089A patent/IL302089A/en unknown
- 2021-10-14 KR KR1020237015789A patent/KR20230088749A/ko active Pending
- 2021-10-14 CA CA3198810A patent/CA3198810A1/en active Pending
- 2021-10-14 JP JP2023523034A patent/JP2023545514A/ja active Pending
- 2021-10-14 WO PCT/US2021/054965 patent/WO2022081835A1/en not_active Ceased
- 2021-10-14 CN CN202180070823.XA patent/CN116390767A/zh active Pending
- 2021-10-14 EP EP21801429.8A patent/EP4228702A1/en active Pending
-
2023
- 2023-04-14 US US18/301,187 patent/US20230279090A1/en active Pending
- 2023-04-14 US US18/301,180 patent/US20230256107A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7597836B2 (ja) | 骨標的抗体 | |
| TWI698447B (zh) | 用於抑制血管新生之融合蛋白 | |
| KR100484084B1 (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| CN117467025B (zh) | 一种抗vegf和补体双功能融合蛋白及其应用 | |
| SK5252001A3 (en) | Modified peptides as therapeutic agents | |
| CN102007145A (zh) | 基于结合egfr的工程化蛋白质的靶向治疗剂 | |
| US20200062814A1 (en) | Modified Latency Associated Protein Construct | |
| CN107206103A (zh) | 用于治疗目的的抗体‑脲酶缀合物 | |
| KR101575194B1 (ko) | 인간 페리틴 유래 융합폴리펩티드 | |
| JPWO2022081835A5 (https=) | ||
| CN111499762A (zh) | 一种包含PDGFRβ特异性亲和体和TNFα的融合蛋白及其用途 | |
| TW202227471A (zh) | 白介素15構建體和使用方法 | |
| JPWO2022079161A5 (https=) | ||
| US20250340604A1 (en) | Blood-brain barrier translocating peptides and related molecules and methods of use thereof | |
| US20260103541A1 (en) | Paracrine Adenoviral Delivery of Biomolecules | |
| CN116162148B (zh) | 多特异性配体结合分子及其应用 | |
| KR20230046999A (ko) | 코일드 코일 융합 단백질 | |
| WO2018219301A1 (zh) | 一种PDGFRβ靶向性肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 | |
| JP7829127B2 (ja) | 抗原結合ドメインおよびサイトカイン三量体ドメインを含む融合タンパク質 | |
| CN113817071B (zh) | 一种egfr靶向的trail融合蛋白及其制备方法和用途 | |
| CN121517576A (zh) | 能够结合VEGF的Fc融合蛋白及其用途 | |
| KR20240026436A (ko) | 단일쇄 가변 단편의 변이 단백질 | |
| WO2025084336A1 (ja) | Ａａｖのキャプシドと標的受容体に同時に結合することができる分子 | |
| JPWO2021083077A5 (https=) | ||
| RU2020129184A (ru) | Способы и композиции для доставки терапевтического белка |